Macjaja64 Posted 12 minutes ago Posted 12 minutes ago Anthropic is one of those companies I’ve been following lately, and the numbers are getting hard to ignore. Reported revenue growth of 1,206% year-on-year is huge, but Claude Code crossing $2.5B in annualized revenue is probably the figure I’d pay more attention to. That’s actual commercial demand, not just people talking about AI. The problem is, following a company and actually getting an opportunity to invest in it are two different things. Traditional IPO access isn’t available to retail investors in every country, which leaves a lot of people watching from the sidelines. This is where I came across Bitget IPO Prime, which offers ANT exposure through rANT. It doesn’t mean you’re buying traditional Anthropic shares, though. rANT is tokenized exposure, and it doesn’t come with shareholder voting rights or direct ownership of the company’s shares. The public subscription had a $100 minimum, with a 5% fee on allocated amounts. It was also oversubscribed, meaning allocations were proportional rather than guaranteed. So committing a certain amount didn’t necessarily mean receiving that same amount in rANT. I think the access part is what makes this worth discussing. A lot of investors outside eligible IPO markets are interested in companies like Anthropic but don’t have the same options available to them. Would you consider tokenized IPO exposure for a company you genuinely believe in, or would you rather wait until it trades publicly and buy through a traditional market? The Anthropic IPO details and rANT access were available through Bitget IPO Prime: https://www.bitget.com/campaigns/anthropic-ipo?channelCode=regd&vipCode=979y
Recommended Posts
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now